Showing results (1-10 of 40) with videos related to
Sort By:
Pageof 4
Somatic Cell Genetics|November 1, 1979
Inheritance of malignancy in somatic cell hybridsG Barski, J BelehradekInternational Journal of Cancer|December 15, 1974
Actinomycin-D-resistant in vitro mouse cell line derived from a methylcholanthrene-induced sarcoma: decrease of malignancy and antigenic characteristicsJ Belehradek, J L Biedler, M Thonier, et al.Biochemical Pharmacology|September 15, 1988
Interaction of cis-diamminedichloroplatinum(II) with sensitive and resistant L1210 cell lines. Drug binding to nuclei and DNAM Foka, J Belehradek, J PaolettiBulletin Du Cancer|December 1, 1994
[Bleomycin is an antineoplastic agent capable of mimicking apoptosis]O Tounekti, J Belehradek, L M MirExperimental Cell Research|April 1, 1995
Relationships between DNA fragmentation, chromatin condensation, and changes in flow cytometry profiles detected during apoptosisO Tounekti, J Belehradek, L M MirBiochemical and Biophysical Research Communications|December 10, 1990
Stable [57Co]-bleomycin complex with a very high specific radioactivity for use at very low concentrationsB Poddevin, J Belehradek, L M MirBiochemical and Biophysical Research Communications|July 15, 1993
Identification of a plasma membrane protein that specifically binds bleomycinG Pron, J Belehradek, L M MirCancer Research|October 1, 1984
Expression of drug sensitivity and tumorigenicity in intraspecies hybrids between 9-hydroxyellipticine-sensitive and -resistant cellsJ J Rémy, J Belehradek, A Jacquemin-SablonEuropean Cytokine Network|November 5, 1997
Host's immune response in electrotherapy of murine tumors by direct currentD Miklavcic, D An, J Belehradek, et al.Biochemical Pharmacology|December 21, 1991
Very high cytotoxicity of bleomycin introduced into the cytosol of cells in cultureB Poddevin, S Orlowski, J Belehradek, et al.Pageof 4